Scholarlink

<p>Cancer remains among the most common causes of mortality and morbidity globally. For millennia, people have utilized herbal medicine for the treatment of various illnesses, including cancer. Multiple research investigations have demonstrated that <i>Withania somnifera</i> possesses significant anti-cancer potential by targeting multiple cancer signalling pathways. Currently, many articles are published regarding <i>Withania somnifera</i> as an anti-cancer agent; however, no SCOPUS-based bibliometric study encompassing a critical analysis of research trends on the subject has been conducted thus far. This review study provides a concise overview of 272 articles published between 2000 and 2024, focusing on research trends and bibliometric studies of anti-cancer properties of <i>Withania somnifera</i>. The article is structured into two main sections. The first section explores global trends, performance analysis metrics, and citation-related metrics. The final section presents a bibliometric evaluation of the research. Data were retrieved from SCOPUS using specific keywords and then manually curated to eliminate duplicates. VOS viewer (version 1.6.20) and Microsoft Excel 2019 were utilized for data visualization. The output of publications about this subject domain reached its peak in 2024. Academia and industry collaborated to publish 2.20% of the articles. The USA (125), India (112), the Department of Pharmacology and Chemical Biology at the University of Pittsburgh (25), the Journal of Ethnopharmacology (25), <i>Withania somnifera</i> (124), and Renu Wadhwa (24) were the most prolific entities in terms of country, institution, publisher, keyword, and author. Withaferin A (47) was the most utilized bioactive compound against cancer, particularly breast cancer (15 studies). Despite the advantageous anti-cancer attributes of <i>Withania somnifera</i>, there remains a deficiency in areas such as clinical data, pharmacokinetic characteristics, safety and toxicity assessments, and effective formulations, which impedes the progression of this potent natural product into clinical development.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

A bibliometric and critical trend analysis of the anti-cancer potential of Withania somnifera during 2000–2024

  • 期刊论文

  • 发表日期：

    2025年10月28日

查看全文
  • Lal Hingorani,
  • Manolina Karmakar,
  • Souvik Mukherjee,
  • Siddharth J. Modi,
  • Vallabh Mulay,
  • Vikram Gota

摘要

Cancer remains among the most common causes of mortality and morbidity globally. For millennia, people have utilized herbal medicine for the treatment of various illnesses, including cancer. Multiple research investigations have demonstrated that Withania somnifera possesses significant anti-cancer potential by targeting multiple cancer signalling pathways. Currently, many articles are published regarding Withania somnifera as an anti-cancer agent; however, no SCOPUS-based bibliometric study encompassing a critical analysis of research trends on the subject has been conducted thus far. This review study provides a concise overview of 272 articles published between 2000 and 2024, focusing on research trends and bibliometric studies of anti-cancer properties of Withania somnifera. The article is structured into two main sections. The first section explores global trends, performance analysis metrics, and citation-related metrics. The final section presents a bibliometric evaluation of the research. Data were retrieved from SCOPUS using specific keywords and then manually curated to eliminate duplicates. VOS viewer (version 1.6.20) and Microsoft Excel 2019 were utilized for data visualization. The output of publications about this subject domain reached its peak in 2024. Academia and industry collaborated to publish 2.20% of the articles. The USA (125), India (112), the Department of Pharmacology and Chemical Biology at the University of Pittsburgh (25), the Journal of Ethnopharmacology (25), Withania somnifera (124), and Renu Wadhwa (24) were the most prolific entities in terms of country, institution, publisher, keyword, and author. Withaferin A (47) was the most utilized bioactive compound against cancer, particularly breast cancer (15 studies). Despite the advantageous anti-cancer attributes of Withania somnifera, there remains a deficiency in areas such as clinical data, pharmacokinetic characteristics, safety and toxicity assessments, and effective formulations, which impedes the progression of this potent natural product into clinical development.